Relief for Chronic Migraines with SphenoCath®

In 2018, Newsletter, Statler, Volume 11 Issue 2 by Addison Clark

Chronic migraine sufferers are finding relief through a quick and painless outpatient procedure known as SphenoCath. SphenoCath, short for sphenopalatine ganglion (SPG) catheter, is a patented method of delivering a sphenopalatine ganglion (SPG) block. SPG is delivered through a flexible catheter that is roughly the diameter of spaghetti pasta. After applying topical anesthetic, the SphenoCath is inserted through the nose. X-ray guidance is used to direct the medication to the sphenopalatine ganglion. The resulting temporary blockade of the SPG has been compared to restarting a malfunctioning computer. After recovering from the blockade, the ganglion begins functioning in a more normal, predictable pattern.

This painless, minimally invasive, 5 minute procedure can provide immediate and long-lasting relief for chronic migraine sufferers.

Dr. Statler, a Board Certified, Fellowship Trained Interventional Radiologist at Virginia Interventional and Vascular Associates (VIVA), has helped many patients who suffer from chronic migraines using SphenoCath. The treatment has had a great impact. “For a subset of patients who suffer from migraines four or more times a year without relief from oral medications, we have found that SphenoCath can help them lead a more normal life.” Along with Dr. Statler, the Board Certified, Fellowship Trained Interventional Radiologists at VIVA are experts at providing this treatment.

Nancy Thomas is one such patient who has benefited from treatment: “I have been suffering with migraines for about twelve years… one to two migraines a week. I found myself both physically and mentally drained. In November 2016, I had my first SphenoCath and have had more procedures since. In the last 7 months, I have had approximately 6 migraines. My quality of life has improved significantly; even my children commented that I seem so much happier. I would recommend this quick and painless procedure to anyone suffering from migraines.”